3-(3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzene-1-sulfonamide, 95%, 1g

1-(Benzofuran-2-yl)-2-bromoethanone, 96%, 1g

5-(2,4-dimethoxyphenyl)-1,2-oxazole-3-carboxylic acid, 95.0%, 2g

3-(4-Chlorophenyl)propylamine, 95.0%, 250mg

methyl tricosanoate, 95.0%, 500mg

SODIUM 6-FLUORO-2-(2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-3-METHYLQUINOLINE-4-CARBOXYLATE, 95.0%, 10mg

1,1-Diphenylethan-1-amine, 97%, 250mg

(2S,6S)-1,2,6-trimethylpiperazine dihydrochloride, 97.0%, 5g

2-(Difluoromethyl)-1,3-difluorobenzene, 98.0%, 1g

5-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE, 95%, 250mg

GC capillary column ROTI®Cap-5, 15 m, 0.32 mm, 0.10 µm, 1 Piece(s)

6-((BENZYLOXY)CARBONYL)-2-(TERT-BUTOXYCARBONYL)-2,6-DIAZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID, 95.0%, 500mg

Fluorescein-5-maleimide (contains 2% N,N-Dimethylformamide at maximum)>97.0%(HPLC)25mg